Data / Form D filings / AIM ImmunoTech Inc.
AIM ImmunoTech Inc.: Form D filings
AIM ImmunoTech Inc., a biotechnology company in Ocala, FL, filed 5 Form D notices with the SEC between 2016 and 2024. The latest, on February 21, 2024, reports $3.3 million sold of a $3.3 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2117 SW HIGHWAY 484, Ocala, FL, 32801
- Phone
- (352) 448-7797
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Florida
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 946644
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | Amendment | $3,301,250 | $3,301,250 | 1 | Feb 16, 2024 | sec.gov | |
| Feb 20, 2024 | New notice | $3,301,250 | $3,301,250 | 1 | Feb 16, 2024 | sec.gov | |
| Apr 25, 2018 | New notice | $25,740 | $25,740 | 3 | Apr 24, 2018 | sec.gov | |
| Feb 13, 2017 | New notice | $18,182 | $18,182 | 4 | Feb 3, 2017 | sec.gov | |
| Sep 2, 2016 | New notice | $33,334 | $33,334 | 3 | Aug 30, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stewart Appelrouth | Director | |
| Thomas Equals | Executive Officer, Director | |
| Nancy Bryan | Director | |
| Rob Dickey | Executive Officer | |
| Peter Rodino | Executive Officer | |
| William Mitchell | Director |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Feb 19, 2024 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AIM ImmunoTech Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.